Fig. 1.

Percent of Patients Requiring Provider Intervention for Management of Pharmacotherapies with New Evidence-Based Cardiovascular Indications.

Figures A-E demonstrate the percent of patients requiring provider interaction to obtain or tolerate pharmacotherapy with new evidence-based cardiovascular indications. Dark blue ​= ​patients requiring provider intervention; light blue ​= ​patients not requiring intervention. Figure A – 64.7% of patients required insurance approval to obtain the medication. Figure B – 37.2% of patients required cost minimization strategies to obtain afford the medication. Figure C – 28.3% of patients required side effect management. Figure D – 73.8% of patients required an intervention for medication access (insurance approval or cost minimization). Figure E − 78.1% of patients required an intervention for medication access and tolerability (insurance approval, cost minimization, or side effect management).